FDG-PET in the Diagnosis of Autoimmune Encephalitis

Launched by UNIVERSITY OF MILANO BICOCCA · Aug 25, 2023

Keywords

ClinConnect Summary

This clinical trial is looking at a type of brain imaging called FDG-PET to help understand autoimmune encephalitis, a condition where the body’s immune system mistakenly attacks the brain. Researchers want to see if patients with autoimmune encephalitis have a unique pattern of brain activity compared to healthy individuals and those with Alzheimer's disease. To do this, they will collect and analyze past medical records, images, and test results from patients who have been diagnosed with autoimmune encephalitis.

To participate in the study, individuals must have been diagnosed with autoimmune encephalitis based on specific clinical guidelines and have undergone certain tests, including brain scans and spinal fluid analysis. The study is open to all genders and aims to gather information from a diverse group of participants. If you or someone you know has been diagnosed with autoimmune encephalitis and is interested in learning more about this study, it could provide valuable insights into this condition and its effects on the brain.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Diagnosis of autoimmune encephalitis according to clinical criteria
• • Brain magnetic resonance imaging performed between clinical presentation and treatment
• • Cerebrospinal fluid analysis performed between clinical presentation and treatment
• • Brain FDG-PET performed between clinical presentation and treatment
• • Autoantibodies testing performed between clinical presentation and treatment
• Exclusion Criteria:
• • Refusal to give consent for the study